Point-of-Care Diagnostics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

GlobalData
April 12, 2012
86 Pages - SKU: GBDT3865607
Countries covered: Global

Point-of-Care Diagnostics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Summary

GlobalData’s new report, “Point-of-Care Diagnostics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018” provides key data, information and analysis on the global Point of Care (POC) diagnostics market. The report provides market landscape, competitive landscape and market trends information on the POC diagnostics market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, and Japan.
  • Key segments covered include Clinical Chemistry, Immuno Chemistry and Hematology.
  • Annualized market revenues data from forecast forward for seven years to 2018. Company shares data for 2011.
  • Qualitative analysis of key market trends, market drivers, and restraints within point of care diagnostics market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include F. Hoffmann-La Roche Ltd., Alere, Inc., Siemens Healthcare and Abbott Laboratories.
Reasons to buy
  • Develop business strategies by understanding the trends and developments that are driving the POC diagnostics market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What’s the next big thing in the POC diagnostics market landscape? – Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global POC diagnostics market and the factors shaping it.



More Diagnostics reports by GlobalData

XEPTAGEN SpA - Product Pipeline Analysis, 2014 Update by GlobalData
SummaryXeptagen SpA (Xeptagen) is a healthcare service provider. The company discovers novel molecular markers to produce diagnostic kits for the early detection, monitoring, and screening ...
Seegene, Inc. (096530) - Product Pipeline Analysis, 2014 Update by GlobalData
SummarySeegene, Inc. (Seegene) is a molecular diagnostic company. The company specializes in molecular diagnostics and develops technology and products. Its products include Anyplex II RV16 ...
Universal Biosensors, Inc. (UBI) - Product Pipeline Analysis, 2014 Update by GlobalData
SummaryUniversal Biosensors, Inc. (UBI) is an Australian medical diagnostic company. The company develops and manufactures in vitro diagnostic test devices that are used for professional ...
TrovaGene, Inc. (TROV) - Product Pipeline Analysis, 2014 Update by GlobalData
SummaryTrovaGene, Inc. (TrovaGene), formally Xenomics, Inc. is a development stage molecular diagnostic company. It develops and commercializes proprietary diagnostic technologies for screening and monitoring of ...
See all reports like this >>

More Global Diagnostics reports

Cardiac Marker Analyzer – Worldwide Analysis by Renub Research
Cardiac Marker Analyzer – Worldwide Analysis Cardiac Marker Analyzer Analysis Point of Care Testing (POCT) enables rapid diagnostic tests to be performed while ...
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide by Renub Research
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide Breast cancer is the most common cancer among women in both the developed ...
Companion Diagnostics Market byTechnology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer), & by End-user (Pharmaceutical Companies, Reference Lab)] - Global Trends & Forecasts to 2019 by MarketsandMarkets
Companion Diagnostics Market byTechnology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer), & by End-user (Pharmaceutical Companies, Reference Lab)] - Global Trends & ...
The World Medical Market Fact Book 2014 by Espicom Healthcare Intelligence
The World Medical Market Fact Book 2014 This report includes multiple year historical data. Where data is not available, BMI estimates have been included. The ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 3,995  
    Site License  USD 7,990  
    Global Site License  USD 11,985  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!